Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Print
An Overview of Regorafenib in Gastrointestinal Cancers: A Lunch Clinical Research Update
Integrating ctDNA in Immune Response Assessment
Saturday, July 2, 2022
14:00 – 14:15
Location: Rooms 133-134; Level 1
Session Speaker(s)
Michel P. Ducreux, MD, PhD
Gustave Roussy
Paris, France
Learning Objectives:
Talking Points: Biomarkers in mCRC(ctDNA)